FLOW CYTOMETRIC MEASUREMENT OF GLUTATHIONE CONTENT OF HUMAN CANCER BIOPSIES

被引:18
作者
HEDLEY, DW
HALLAHAN, AR
TRIPP, EH
机构
[1] UNIV SYDNEY,FAC MED,SCH CLIN,SYDNEY,NSW 2006,AUSTRALIA
[2] UNIV SYDNEY,LUDWIG INST CANC RES,SYDNEY,NSW 2006,AUSTRALIA
关键词
D O I
10.1038/bjc.1990.14
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Rice et al. (1986) have described a flow cytometric method where the non-fluorescent probe monochlorobimane (mBCl) forms a fluorescent adduct with cellular glutathione (GSH) under the action of glutathione-S-transferase. We show here that for EMT6 carcinosarcoma cells there is a close correlation between mean cell fluorescence, expressed as a ratio to that of fluorescence calibration beads, and biochemically determined GSH content over the range 0.2-2.0 fmol cell-1. Single cell suspensions from 14 human cancers were prepared by 23-gauge needle aspiration or mechanical disaggregation of surgical specimens, stained using mBCl and examined by flow cytometry. There was a wide range in individual cell fluorescence, which in contrast to EMT6 cells was not strongly correlated with Coulter volume. By comparing tumour cell fluorescence to that of calibration beads, and assuming that the relationship with GSH content for EMT6 holds for other cells, a mean GSH content of 0.95 fmol cell-1 was derived for nine carcinomas, and 0.21 fmol cell-1 for five non-Hodgkin’s lymphomas. Although this semi-quantitation needs further validation, the method used here is rapid, gives an indication of heterogeneity of tumour cell GSH content, and can be applied to fine needle biopsy samples. It therefore shows promise as a means for studying prospectively the relationship of GSH content to clinical drug and radiation sensitivity, and for monitoring the effects of agents such as buthionine sulphoximine which are intended to improve treatment results through tumour cell GSH depletion. © Macmillan Press Ltd., 1990.
引用
收藏
页码:65 / 68
页数:4
相关论文
共 12 条
[1]   USE OF MONOCHLOROBIMANE FOR GLUTATHIONE MEASUREMENTS IN HAMSTER AND HUMAN-TUMOR CELL-LINES [J].
COOK, JA ;
PASS, HI ;
RUSSO, A ;
IYPE, S ;
MITCHELL, JB .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (05) :1321-1324
[2]  
DEFFIE AM, 1988, CANCER RES, V48, P3595
[3]   EVALUATION OF THE MICROMETHOD FOR DETERMINATION OF GLUTATHIONE USING ENZYMATIC CYCLING AND ELLMAN REAGENT [J].
EYER, P ;
PODHRADSKY, D .
ANALYTICAL BIOCHEMISTRY, 1986, 153 (01) :57-66
[4]   ROLE OF THE GLUTATHIONE REDOX CYCLE IN ACQUIRED AND DENOVO MULTIDRUG RESISTANCE [J].
KRAMER, RA ;
ZAKHER, J ;
KIM, G .
SCIENCE, 1988, 241 (4866) :694-697
[5]   DEPLETION OF TUMOR VERSUS NORMAL TISSUE GLUTATHIONE BY BUTHIONINE SULFOXIMINE [J].
LEE, FYF ;
ALLALUNISTURNER, MJ ;
SIEMANN, DW .
BRITISH JOURNAL OF CANCER, 1987, 56 (01) :33-38
[6]   GLUTATHIONE [J].
MEISTER, A ;
ANDERSON, ME .
ANNUAL REVIEW OF BIOCHEMISTRY, 1983, 52 :711-760
[7]   A FLOW CYTOMETRIC ASSAY FOR INTRACELLULAR NONPROTEIN THIOLS USING MERCURY ORANGE [J].
OCONNOR, JE ;
KIMLER, BF ;
MORGAN, MC ;
TEMPAS, KJ .
CYTOMETRY, 1988, 9 (06) :529-532
[8]   ENHANCED MELPHALAN CYTOTOXICITY IN HUMAN OVARIAN-CANCER INVITRO AND IN TUMOR-BEARING NUDE-MICE BY BUTHIONINE SULFOXIMINE DEPLETION OF GLUTATHIONE [J].
OZOLS, RF ;
LOUIE, KG ;
PLOWMAN, J ;
BEHRENS, BC ;
FINE, RL ;
DYKES, D ;
HAMILTON, TC .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (01) :147-153
[9]  
RICE GC, 1986, CANCER RES, V46, P6105
[10]  
SHRIEVE DC, 1988, J BIOL CHEM, V263, P14107